In patients with normal initial level of CEA, the postoperative CEA level and variations may be effective markers for evaluating tumor progress; TNM staging combined with CEA levels may be more accurate in the prognostic prediction of CRC patients [30]. The gene discussed is CEACAM5; the disease is colorectal carcinoma.